The regulatory role of activating transcription factor 2 in inflammation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Yu, Tao ^a,b   Li, Yong Jun ^a   Bian, Ai Hong ^c   Zuo, Hui Bin ^a   Zhu, Ti Wen ^a   Ji, Sheng Xiang ^a   Kong, Fanming ^a   Yin, De Qing ^a   Wang, Chuan Bao ^a   Wang, Zi Fu ^a   Wang, Hong Qun ^a   Yang, Yanyan ^b   Yoo, Byong Chul ^d   Cho, Jae Youl ^b  

^a Linyi Center for Disease Control and Prevention   (China)

^b Sungkyunkwan University   (South Korea)

^c Laiwu Center for Disease Control and Prevention   (China)

^d National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; ANDROGRAPHOLIDE; ANTIINFLAMMATORY AGENT; BERBERINE; BIOCHANIN A; GENISTEIN; HANGAMDAN B; HERBACEOUS AGENT; ISOFLAVONE; JIANPI JIEDU; JIP 1; NOMILIN; PIMARIC ACID; PIPERINE; PLANT EXTRACT; SCHIZONEPETA TENUIFOLIA EXTRACT; UNCLASSIFIED DRUG; ATF2 PROTEIN, HUMAN;

ALLERGIC ASTHMA; CLINICAL TRIAL (TOPIC); HEPATITIS; HUMAN; INFLAMMATION; INFLAMMATORY PAIN; MEDICINAL PLANT; OBESITY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SCHIZONEPETA TENUIFOLIA; SIGNAL TRANSDUCTION; APOPTOSIS; CELL PROLIFERATION; METABOLISM; PHYSIOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 2; APOPTOSIS; CELL PROLIFERATION; HUMANS; INFLAMMATION;

EID: 84904114044     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/950472     Document Type: Review

References (91)

1. Ferrero-Miliani L., Nielsen O. H., Andersen P. S., Girardin S. E., Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1 β generation. Clinical and Experimental Immunology 2007 147 2 227 235 2-s2.0-33846257261 10.1111/j.1365-2249.2006.03261.x (Pubitemid 46095999)
2. Ham M., Moon A., Inflammatory and microenvironmental factors involved in breast cancer progression. Archives of Pharmacal Research 2013 36 12 1419 1431
3. Yu T., Yi Y.-S., Yang Y., Oh J., Jeong D., Cho J. Y., The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Mediators of Inflammation 2012 2012 8 2-s2.0-84871649863 10.1155/2012/979105 979105
4. Byeon S. E., Yi Y.-S., Oh J., Yoo B. C., Hong S., Cho J. Y., The role of Src kinase in macrophage-mediated inflammatory responses. Mediators of Inflammation 2012 2012 18 2-s2.0-84871369699 10.1155/2012/512926 512926
5. Im D. S., Intercellular lipid mediators and GPCR drug discovery. Biomolecules and Therapeutics 2013 21 6 411 422
6. Youn C. K., Park S. J., Lee M. Y., Cha M. J., Kim O. H., You H. J., Chang I. Y., Yoon S. P., Jeon Y. J., Silibinin inhibits LPS-induced macrophage activation by blocking p38 MAPK in RAW 264.7 cells. Biomolecules and Therapeutics 2013 21 4 258 263 2-s2.0-84881062695 10.4062/biomolther.2013.044
7. Ovchinnikov D. A., Macrophages in the embryo and beyond: much more than just giant phagocytes. Genesis 2008 46 9 447 462 2-s2.0-58049097873 10.1002/dvg.20417
8. Kim M.-Y., Cho J. Y., 20S-dihydroprotopanaxadiol, a ginsenoside derivative, boosts innate immune responses of monocytes and macrophages. Journal of Ginseng Research 2013 37 3 293 299 2-s2.0-84880063627 10.5142/jgr.2013.37. 293
9. Hyun B., Shin S., Lee A., Metformin down-regulates TNF-alpha secretion via suppression of scavenger receptors in macrophages. Immune Network 2013 13 4 123 132
10. Seo B. S., Lee S. H., Lee J. E., Yoo Y. C., Lee J., Park S. R., Dectin-1 stimulation selectively reinforces LPS-driven IgG1 production by mouse B cells. Immune Network 2013 13 5 205 212
11. Park M. C., Kim D., Lee Y., Kwon H. J., CD83 expression induced by CpG-DNA stimulation in a macrophage cell line RAW 264.7. BMB Reports 2013 46 9 448 453
12. Taylor P. R., Martinez-Pomares L., Stacey M., Lin H.-H., Brown G. D., Gordon S., Macrophage receptors and immune recognition. Annual Review of Immunology 2005 23 901 944 2-s2.0-11844254888 10.1146/annurev.immunol.23.021704. 115816 (Pubitemid 40563189)
13. Kim D. H., Chung J. H., Yoon J. S., Ha Y. M., Bae S., Lee E. K., Jung K. J., Kim M. S., Kim Y. J., Kim M. K., Chung H. Y., Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF- B in LPS-stimulated RAW264.7 cells and mouse liver. Journal of Ginseng Research 2013 37 1 54 63 2-s2.0-84872244336 10.5142/jgr.2013.37.54
14. Chen H. H., Lai P. F., Lan Y. F., Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion. Journal of Cellular Physiology 2014 229 9 1202 1211
15. Lai P. F., Cheng C. F., Lin H., Tseng T. L., Chen H. H., Chen S. H., ATF3 protects against LPS-induced inflammation in mice via inhibiting HMGB1 expression. Evidence-Based Complementary and Alternative Medicine 2013 2013 14 716481 10.1155/2013/716481
16. Wang L., Deng S., Lu Y., Zhang Y., Yang L., Guan Y., Jiang H., Li H., Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice. Neuroscience 2012 220 100 108 2-s2.0-84864740234 10.1016/j.neuroscience.2012.06.010
17. Tanaka K., Kanno T., Yanagisawa Y., Yasutake K., Hadano S., Yoshii F., Ikeda J.-E., Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology 2011 232 1 41 52 2-s2.0-80053934803 10.1016/j.expneurol. 2011.08.001
18. Cheng C.-F., Lin H., Acute kidney injury and the potential for ATF3-regulated epigenetic therapy. Toxicology Mechanisms and Methods 2011 21 4 362 366 2-s2.0-79954481568 10.3109/15376516.2011.557876
19. Li H.-F., Cheng C.-F., Liao W.-J., Lin H., Yang R.-B., ATF3-mediated epigenetic regulation protects against acute kidney injury. Journal of the American Society of Nephrology 2010 21 6 1003 1013 2-s2.0-77952980817 10.1681/ASN.2009070690
20. Akram A., Han B., Masoom H., Peng C., Lam E., Litvack M. L., Bai X., Shan Y., Hai T., Batt J., Slutsky A. S., Zhang H., Kuebler W. M., Haitsma J. J., Liu M., Dos Santos C. C., Activating transcription factor 3 confers protection against ventilator-induced lung injury. The American Journal of Respiratory and Critical Care Medicine 2010 182 4 489 500 2-s2.0-77957088754 10.1164/rccm.200906-0925OC
21. Gilchrist M., Henderson W. R. Jr., Clark A. E., Simmons R. M., Ye X., Smith K. D., Aderem A., Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. Journal of Experimental Medicine 2008 205 10 2349 2357 2-s2.0-53349122333 10.1084/jem.20072254
22. Gurzov E. N., Barthson J., Marhfour I., Ortis F., Naamane N., Igoillo-Esteve M., Gysemans C., Mathieu C., Kitajima S., Marchetti P., Ørntoft T. F., Bakiri L., Wagner E. F., Eizirik D. L., Pancreatic β -cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene 2012 31 13 1723 1732 2-s2.0-84859436112 10.1038/onc.2011.353
23. Suganami T., Yuan X., Shimoda Y., Uchio-Yamada K., Nakagawa N., Shirakawa I., Usami T., Tsukahara T., Nakayama K., Miyamoto Y., Yasuda K., Matsuda J., Kamei Y., Kitajima S., Ogawa Y., Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated fatty Acid/Toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circulation Research 2009 105 1 25 32 2-s2.0-67949091182 10.1161/CIRCRESAHA.109. 196261
24. Tacke F., Liedtke C., Bocklage S., Manns M. P., Trautwein C., CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005 54 9 1309 1317 2-s2.0-23944481332 10.1136/gut.2005.065086 (Pubitemid 41192494)
25. Zhong Y., Li J., Chen Y., Wang J. J., Ratan R., Zhang S. X., Activation of endoplasmic reticulum stress by hyperglycemia is essential for Müller cell-derived inflammatory cytokine production in diabetes. Diabetes 2012 61 2 492 504 2-s2.0-84863081447 10.2337/db11-0315
26. Gargalovic P. S., Imura M., Zhang B., Gharavi N. M., Clark M. J., Pagnon J., Yang W.-P., He A., Truong A., Patel S., Nelson S. F., Horvath S., Berliner J. A., Kirchgessner T. G., Lusis A. J., Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proceedings of the National Academy of Sciences of the United States of America 2006 103 34 12741 12746 2-s2.0-33748048164 10.1073/pnas.0605457103 (Pubitemid 44298631)
27. Giudice A., Arra C., Turco M. C., Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods in Molecular Biology 2010 647 37 74 2-s2.0-79952108221 10.1007/978-1-60761-738-9-3
28. Kochetov A. V., Merkulova T. I., Merkulov V. M., Possible link between the synthesis of GR alpha isoforms and eIF2 alpha phosphorylation state. Medical Hypotheses 2012 79 6 709 712 2-s2.0-84869091768 10.1016/j.mehy.2012.07.025
29. Monaco S. E., Angelastro J. M., Szabolcs M., Greene L. A., The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. International Journal of Cancer 2007 120 9 1883 1890 2-s2.0-33947232832 10.1002/ijc.22469 (Pubitemid 46418363)
30. Yamazaki H., Hiramatsu N., Hayakawa K., Tagawa Y., Okamura M., Ogata R., Huang T., Nakajima S., Yao J., Paton A. W., Paton J. C., Kitamura M., Activation of the Akt-NF- B pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. Journal of Immunology 2009 183 2 1480 1487 2-s2.0-69849109361 10.4049/jimmunol.0900017
31. Kerbiriou M., Le Drévo M.-A., Férec C., Trouvé P., Coupling cystic fibrosis to endoplasmic reticulum stress: differential role of Grp78 and ATF6. Biochimica et Biophysica Acta: Molecular Basis of Disease 2007 1772 11-12 1236 1249 2-s2.0-36849077205 10.1016/j.bbadis.2007.10.004 (Pubitemid 350235183)
32. Teramachi J., Hiruma Y., Ishizuka S., Ishizuka H., Brown J. P., Michou L., Cao H., Galson D. L., Subler M. A., Zhou H., Dempster D. W., Windle J. J., Roodman G. D., Kurihara N., Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease. Journal of Bone and Mineral Research 2013 28 6 1489 1500 2-s2.0-84878263632 10.1002/jbmr.1884
33. Pescini R., Kaszubska W., Whelan J., DeLamarter J. F., van Huijsduijnen R. H., ATF-aO, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers. Journal of Biological Chemistry 1994 269 2 1159 1165 2-s2.0-0028167550
34. Maekawa T., Jin W., Ishii S., The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Molecular and Cellular Biology 2010 30 3 613 625 2-s2.0-75149173154 10.1128/MCB.00685-09
35. Shen T., Yang W. S., Yi Y.-S., Sung G.-H., Rhee M. H., Poo H., Kim M.-Y., Kim K.-W., Kim J. H., Cho J. Y., AP-1/IRF-3 targeted anti-inflammatory activity of andrographolide isolated from andrographis paniculata. Evidence-Based Complementary and Alternative Medicine 2013 2013 16 2-s2.0-84879316992 10.1155/2013/210736 210736
36. Recio J. A., Merlino G., Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 2002 21 7 1000 1008 2-s2.0-0037034199 10.1038/sj/onc/1205150 (Pubitemid 34174512)
37. Kole L., Giri B., Manna S. K., Pal B., Ghosh S., Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking NF B nuclear translocation. European Journal of Pharmacology 2011 653 1-3 8 15 2-s2.0-78651505391 10.1016/j.ejphar.2010.11.026
38. Suh S.-J., Kwak C.-H., Chung T.-W., Park S. J., Cheeeei M., Park S.-S., Seo C.-S., Son J.-K., Chang Y.-C., Park Y.-G., Lee Y.-C., Chang H. W., Kim C.-H., Pimaric acid from Aralia cordata has an inhibitory effect on TNF- α -induced MMP-9 production and HASMC migration via down-regulated NF- B and AP-1. Chemico-Biological Interactions 2012 199 2 112 119 2-s2.0-84864354721 10.1016/j.cbi.2012.06.003
39. Pratheeshkumar P., Raphael T. J., Kuttan G., Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells. Integrative Cancer Therapies 2012 11 1 48 60 2-s2.0-84861831365 10.1177/1534735411403307
40. Feng A.-W., Yu C., Mao Q., Li N., Li Q.-R., Li J.-S., Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia. Fitoterapia 2011 82 7 976 982 2-s2.0-80052139394 10.1016/j.fitote.2011.05.013
41. Vela E. M., Bowick G. C., Herzog N. K., Aronson J. F., Genistein treatment of cells inhibits arenavirus infection. Antiviral Research 2008 77 2 153 156 2-s2.0-38149016369 10.1016/j.antiviral.2007.09.005
42. Pradeep C. R., Kuttan G., Piperine is a potent inhibitor of nuclear factor- B (NF- B), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. International Immunopharmacology 2004 4 14 1795 1803 2-s2.0-8644238077 10.1016/j.intimp.2004.08.005 (Pubitemid 39504820)
43. Kang H., Han S.-W., Hong J.-W., Sohn N.-W., Suppression of tumour necrosis factor- α by Schizonepeta tenuifolia water extract via inhibition of I B α degradation and Jun N-terminal kinase/stress-activated protein kinase activation. Journal of Pharmacy and Pharmacology 2010 62 8 1069 1076 2-s2.0-77954922229 10.1111/j.2042-7158.2010.01126.x
44. Yu T., Moh S. H., Kim S.-B., Yang Y., Kim E., Lee Y.-W., Cho C.-K., Kim K.-H., Yoo B. C., Cho J. Y., Yoo H.-S., HangAmDan-B, an ethnomedicinal herbal mixture, suppresses inflammatory responses by inhibiting Syk/NF- B and JNK/ATF-2 pathways. Journal of Medicinal Food 2013 16 1 56 65 2-s2.0-84872119707 10.1089/jmf.2012.2374
45. Liu N.-N., Wang Y., Wu Q., Jianpi jiedu recipe inhibited Helicobacter pylori-induced the expression of cyclooxygenase-2 via p38MAPK/ATF-2 signal transduction pathway in human gastric cancer cells. Zhongguo Zhong xi yi jie he za zhi 2011 31 7 926 931 2-s2.0-84880897369
46. Ozawa K., Sudo T., Soeda E.-I., Yoshida M. C., Ishii S., Assignment of the human CREB2 (CRE-BP1) Gene to 2Q32. Genomics 1991 10 4 1103 1104 2-s2.0-0026212261
47. Bhoumik A., Takahashi S., Breitweiser W., Shiloh Y., Jones N., Ronai Z., ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. Molecular Cell 2005 18 5 577 587 2-s2.0-19444363740 10.1016/j.molcel.2005.04.015 (Pubitemid 40726234)
48. Hummler E., Cole T. J., Blendy J. A., Ganss R., Aguzzi A., Schmid W., Beermann F., Schütz G., Targeted mutation of the CREB gene: compensation within the CREB/ATF family of transcription factors. Proceedings of the National Academy of Sciences of the United States of America 1994 91 12 5647 5651 2-s2.0-0028238472 10.1073/pnas.91.12.5647 (Pubitemid 24174385)
49. Vlahopoulos S. A., Logotheti S., Mikas D., Giarika A., Gorgoulis V., Zoumpourlis V., The role of ATF-2 in oncogenesis. BioEssays 2008 30 4 314 327 2-s2.0-41649111688 10.1002/bies.20734 (Pubitemid 351482329)
50. Nomura N., Zu Y.-L., Maekawa T., Tabata S., Akiyama T., Ishii S., Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1. Journal of Biological Chemistry 1993 268 6 4259 4266 2-s2.0-0027506077 (Pubitemid 23072966)
51. Gaire M., Chatton B., Kedinger C., Isolation and characterization of two novel, closely related ATF cDNA clones from HeLa cells. Nucleic Acids Research 1990 18 12 3467 3473 2-s2.0-0025296684
52. Zu Y.-L., Maekawa T., Matsuda S., Ishii S., Complete putative metal finger and leucine zipper structures of CRE-BP1 are required for the E1A-induced trans-activation. Journal of Biological Chemistry 1991 266 35 24134 24139 2-s2.0-0026346996 (Pubitemid 21908917)
53. Takeda J., Maekawa T., Sudo T., Seino Y., Imura H., Naoaki S., Tanaka C., Ishii S., Expression of the CRE-BP1 transcriptional regulator binding to the cyclic AMP response element in central nervous system, regenerating liver, and human tumors. Oncogene 1991 6 6 1009 1014 2-s2.0-0025744213 (Pubitemid 21924179)
54. Goetz J., Chatton B., Mattei M.-G., Kedinger C., Structure and expression of the ATFa gene. Journal of Biological Chemistry 1996 271 47 29589 29598 2-s2.0-0029860519 10.1074/jbc.271.47.29589 (Pubitemid 26389580)
55. Liu H., Deng X., Shyu Y. J., Jian J. L., Taparowsky E. J., Hu C.-D., Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. The EMBO Journal 2006 25 5 1058 1069 2-s2.0-33644853153 10.1038/sj.emboj.7601020 (Pubitemid 43372119)
56. Lau E., Ronai Z. A., ATF2: at the crossroad of nuclear and cytosolic functions. Journal of Cell Science 2012 125 12 2815 2824 2-s2.0-84867904006 10.1242/jcs.095000
57. Ouwens D. M., de Ruiter N. D., van der Zon G. C. M., Carter A. P., Schouten J., van der Burgt C., Kooistra K., Bos J. L., Maassen J. A., van Dam H., Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RaIGDS-Src-p38. The EMBO Journal 2002 21 14 3782 3793 2-s2.0-18444411948 10.1093/emboj/cdf361 (Pubitemid 34787051)
58. Gupta S., Campbell D., Derijard B., Davis R. J., Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 1995 267 5196 389 393 2-s2.0-0028905076
59. Livingstone C., Patel G., Jones N., ATF-2 contains a phosphorylation- dependent transcriptional activation domain. The EMBO Journal 1995 14 8 1785 1797 2-s2.0-0029034251
60. Raingeaud J., Gupta S., Rogers J. S., Dickens M., Han J., Ulevitch R. J., Davis R. J., Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry 1995 270 13 7420 7426 2-s2.0-0028935270 10.1074/jbc.270.13.7420
61. Hayakawa J., Depatie C., Ohmichi M., Mercola D., The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. Journal of Biological Chemistry 2003 278 23 20582 20592 2-s2.0-0038757747 10.1074/jbc.M210992200 (Pubitemid 36806356)
62. Beier F., Taylor A. C., LuValle P., Activating transcription factor 2 is necessary for maximal activity and serum induction of the cyclin A promoter in chondrocytes. Journal of Biological Chemistry 2000 275 17 12948 12953 2-s2.0-0034725079 10.1074/jbc.275.17.12948 (Pubitemid 30241452)
63. Hayakawa J., Mittal S., Wang Y., Korkmaz K. S., Adamson E., English C., Omichi M., McClelland M., Mercola D., Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. Molecular Cell 2004 16 4 521 535 2-s2.0-8844285956 10.1016/j.molcel.2004.10.024 (Pubitemid 39531876)
64. Vlahopoulos S., Zoumpourlis V. C., JNK: a key modulator of intracellular signaling. Biochemistry 2004 69 8 844 854 2-s2.0-4444287774 10.1023/B:BIRY. 0000040215.02460.45
65. Chan C.-P., Chang M.-C., Wang Y.-J., Chen L.-I., Tsai Y.-L., Lee J.-J., Jia H.-W., Jeng J.-H., Thrombin activates Ras-CREB/ATF-1 signaling and stimulates c-fos, c-jun, and c-myc expression in human gingival fibroblasts. Journal of Periodontology 2008 79 7 1248 1254 2-s2.0-47749119561 10.1902/jop.2008.070523
66. Pernhorst K., Herms S., Hoffmann P., TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue. Seizure 2013 22 8 675 678
67. Miyata Y., Fukuhara A., Otsuki M., Shimomura I., Expression of activating transcription factor 2 in inflammatory macrophages in obese adipose tissue. Obesity 2013 21 4 731 736 2-s2.0-84878286589 10.1002/oby.20274
68. Fang J.-Q., Du J.-Y., Liang Y., Fang J.-F., Intervention of electroacupuncture on spinal p38 MAPK/ATF-2/VR-1 pathway in treating inflammatory pain induced by CFA in rats. Molecular Pain 2013 9 1, article 13 2-s2.0-84875138242 10.1186/1744-8069-9-13
69. Akiyama Y., Ogawa F., Iwata Y., Komura K., Hara T., Muroi E., Bae S.-J., Takenaka M., Shimizu K., Hasegawa M., Fujimoto M., Sato S., Autoantibody against activating transcription factor-2 in patients with systemic sclerosis. Clinical and Experimental Rheumatology 2009 27 5 751 757 2-s2.0-72949112676
70. Reimold A. M., Kim J., Finberg R., Glimcher L. H., Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice. International Immunology 2001 13 2 241 248 2-s2.0-0035140889 (Pubitemid 32123958)
71. Dinarello C. A., Proinflammatory cytokines. Chest 2000 118 2 503 508 2-s2.0-0033874108 (Pubitemid 30637822)
72. Desch M., Hackmayer G., Todorov V. T., Identification of ATF2 as a transcriptional regulator of renin gene. Biological Chemistry 2012 393 1-2 93 100 2-s2.0-84856206146 10.1515/BC-2011-157
73. Takeda K., Akira S., TLR signaling pathways. Seminars in Immunology 2004 16 1 3 9 2-s2.0-0742324860 10.1016/j.smim.2003.10.003 (Pubitemid 38147427)
74. Blasius A. L., Beutler B., Intracellular toll-like receptors. Immunity 2010 32 3 305 315 2-s2.0-77949940198 10.1016/j.immuni.2010.03.012
75. Kawai T., Akira S., The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nature Immunology 2010 11 5 373 384 2-s2.0-77951260924 10.1038/ni.1863
76. Li X., Jiang S., Tapping R. I., Toll-like receptor signaling in cell proliferation and survival. Cytokine 2010 49 1 1 9 2-s2.0-71649086180 10.1016/j.cyto.2009.08.010
77. Miggin S. M., O'Neill L. A. J., New insights into the regulation of TLR signaling. Journal of Leukocyte Biology 2006 80 2 220 226 2-s2.0-33748871535 10.1189/jlb.1105672 (Pubitemid 44835495)
78. Li X.-Y., Green M. R., Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes and Development 1996 10 5 517 527 2-s2.0-0030007235 (Pubitemid 26091764)
79. de Cesare D., Vallone D., Caracciolo A., Sassone-Corsi P., Nerlov C., Verde P., Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 1995 11 2 365 376 2-s2.0-0028981659
80. Lee J., Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 Diabetes. Archives of Pharmacal Research 2013 36 2 208 222 2-s2.0-84879498251 10.1007/s12272-013-0023-8
81. Kweon H.-J., Suh B.-C., Acid-sensing ion channels (ASICs): therapeutic targets for neurological diseases and their regulation. BMB Reports 2013 46 6 295 304 2-s2.0-84880597393 10.5483/BMBRep.2013.46.6.121
82. Skupsky J., Hu K. Q., Current hepatitis B treatment guidelines and future research directions. Frontiers of Medicine 2014 8 2 145 157
83. Choi C. Y., Choi B. H., Park G. T., Rho H. M., Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer. Journal of Biological Chemistry 1997 272 27 16934 16939 2-s2.0-0000584660 10.1074/jbc.272.27.16934 (Pubitemid 27289795)
84. Breitwieser W., Lyons S., Flenniken A. M., Ashton G., Bruder G., Willington M., Lacaud G., Kouskoff V., Jones N., Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells. Genes and Development 2007 21 16 2069 2082 2-s2.0-34547946030 10.1101/gad.430207 (Pubitemid 47267292)
85. Bickford J. S., Newsom K. J., Herlihy J.-D., Mueller C., Keeler B., Qiu X., Walters J. N., Su N., Wallet S. M., Flotte T. R., Nick H. S., Induction of group IVC phospholipase A2 in allergic asthma: transcriptional regulation by TNF α in bronchoepithelial cells. Biochemical Journal 2012 442 1 127 137 2-s2.0-84856271071 10.1042/BJ20111269
86. Liao H., Hyman M. C., Baek A. E., Fukase K., Pinsky D. J., cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. Journal of Biological Chemistry 2010 285 19 14791 14805 2-s2.0-77951983618 10.1074/jbc.M110.116905
87. Licht A. H., Pein O. T., Florin L., Hartenstein B., Reuter H., Arnold B., Lichter P., Angel P., Schorpp-Kistner M., JunB is required for endothelial cell morphogenesis by regulating core-binding factor β Journal of Cell Biology 2006 175 6 981 991 2-s2.0-33845702755 10.1083/jcb.200605149 (Pubitemid 44969203)
88. Pearson A. G., Curtis M. A., Waldvogel H. J., Faull R. L. M., Dragunow M., Activating transcription factor 2 expression in the adult human brain: association with both neurodegeneration and neurogenesis. Neuroscience 2005 133 2 437 451 2-s2.0-19444375908 10.1016/j.neuroscience.2005.02.029 (Pubitemid 40726211)
89. Fledderus J. O., van Thienen J. V., Boon R. A., Dekker R. J., Rohlena J., Volger O. L., Bijnens A.-P. J. J., Daemen M. J. A. P., Kuiper J., van Berkel T. J. C., Pannekoek H., Horrevoets A. J. G., Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood 2007 109 10 4249 4257 2-s2.0-34248350010 10.1182/blood-2006-07-036020 (Pubitemid 46743390)
90. Hu M. C., Wasserman D., Hartwig S., Rosenblum N. D., p38MAPK acts in the BMP7-dependent stimulatory pathway during epithelial cell morphogenesis and is regulated by Smad1. Journal of Biological Chemistry 2004 279 13 12051 12059 2-s2.0-1842425809 10.1074/jbc.M310526200 (Pubitemid 38445767)
91. Faour W. H., Alaaeddine N., Mancini A., Qing W. H., Jovanovic D., Di Battista J. A., Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor- α gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts. Journal of Biological Chemistry 2005 280 10 9536 9546 2-s2.0-15744387863 10.1074/jbc.M414067200 (Pubitemid 40409649)